Aggregate Asset Value: Ikena Oncology, Inc. (IMA)
ImageneBio Inc (IMA) specializes in developing precision cancer treatments. This daily price chart reflects the impact of AI-driven drug design automation and robotics, with total assets amounting to 141.35. The business focuses on identifying molecular vulnerabilities in tumors to block them with precision. Steady market confidence confirms the company's status as a disciplined developer of high-quality clinical solutions.
Financial and market metric breakdowns for ikenaoncology.com (IMA)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Analysis of all company metrics:ImageneBio Inc
This indicator reverse-calculates the total value of resources via return on assets (ROA), reflecting the actual scale of the business and capital efficiency. For ImageneBio Inc (IMA), the assessment of total asset value demonstrates how venture capital supports the development of the immuno-oncology pipeline, allowing investors to track the company's financial stability during the early stages of drug development.
Competitor analysis for ImageneBio Inc
argenx.com (ARGX) - Total Asset Value of Company|BNTX - Company Total Assets|Aggregate Asset Value Abivax|Company Total Assets ADMA|Company Total Assets PTGX (Protagonist Corp)|Aggregate Company Assets Immunovant, Inc.|kiniksa.com - Aggregate Asset Value|GRFS: Aggregate Company Assets|ADPT - Cumulative Company Assets|CLDX: Company Total Assets|Company Total Assets Aurinia Corp|BCRX - Cumulative Company Assets|Aggregate Asset Value veratx.com|DNTH (Dianthus Therapeutics, Inc.) - Company Total Assets|Company Total Asset Base PHVS (Pharvaris NV)|abcellera.com - Aggregate Company Assets|Tourmaline - Cumulative Company Assets|PGEN: Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|NKTR: Cumulative Company Assets|UPB (Upstream Bio, Inc.) - Company Total Assets|Aggregate Company Assets Zenas Biopharma, Inc. (ZBIO)|Total Business Assets Immunome Bio|Gossamer Bio, Inc. - Company Total Assets|Company Assets kalvista.com (KALV)|Company Total Assets SEPN|Pieris Pharma - Company Total Asset Base|SVRA: Aggregate Company Assets|RIGL - Cumulative Company Assets|ANAB: Company Total Assets|astriatx.com (ATXS) - Company Total Assets|enGene - Company Total Assets|Company Balance Sheet Assets RAPT Therapeutics Inc.|Aerovate Therapeutics Inc - Company Total Assets|Company Assets ACRS (Aclaris Therapeutics, Inc)|KYTX - Aggregate Company Assets|Total Business Assets tizianalifesciences.com TLSA|CABA (Cabaletta Bio) - Company Total Assets|VTYX - Company Assets|Theratechnologies Inc (THTX) - Company Total Assets|Avalo Therapeutics Inc (AVTX) - Aggregate Company Assets|ELDN: Company Total Assets|Company Total Asset Base AGEN|Climb Bio - Aggregate Company Assets|Company Assets Zura Bio Ltd ZURA|Cumulative Company Assets aTyr|Aggregate Asset Value Adagene Inc ADAG|Company Total Assets STTK (Shattuck Therapeutics)|EQ: Company Total Asset Base|Aggregate Company Assets connectbiopharm.com|Immunic (IMUX) - Total Business Assets|Company Total Assets ATRA|Cumulative Company Assets InflaRx GmbH|XFOR (X4 Pharmaceuticals) - Company Total Assets|Company Total Asset Base ACET (adicetbio.com)|Celularity - Aggregate Company Assets|Cumulative Company Assets INmune Bio Inc INMB|Barinthus Bio - Company Total Assets|KZR: Company Total Assets|Aggregate Company Assets SAB Biotherapeutics (SABS)|akaritx.com (AKTX) - Total Asset Value of Company|ENLV - Company Total Assets|Aggregate Asset Value Q32 Bio Corp|Company Total Assets GOVX|Company Total Assets EDSA (Edesa Biotech Corp)|Aggregate Company Assets iBio, Inc.|Carisma Therapeutics Inc - Aggregate Asset Value|XTLB: Aggregate Company Assets|BOLT - Cumulative Company Assets|HCWB: Company Total Assets|Company Total Assets Aptevo Therapeutics Inc.|AIM - Cumulative Company Assets|Aggregate Asset Value Aditxt Corp|GRI (GRI Bio) - Company Total Assets|Company Total Asset Base XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences - Aggregate Company Assets|Revelation Biosciences Corp - Cumulative Company Assets|INDP: Aggregate Company Assets|scinai.com (SCNI) - Cumulative Company Assets|CALI: Cumulative Company Assets|AFMD (Affimed N.V.) - Company Total Assets|Aggregate Company Assets Allakos Inc (ALLK)|Total Business Assets HOOKIPA|IGM Biosciences, Inc. - Company Total Assets|Company Assets iteostherapeutics.com (ITOS)|Company Total Assets OCEA|TC BioPharm (Holdings) Plc - Company Total Asset Base|THRD: Aggregate Company Assets